Skip to content
News

Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models

Ten63 is a Duke University start-up founded by Professor Bruce Donald (Computer Science, Trinity), and his students. Ten63 is also a Duke Capital Partners portfolio company.